Literature DB >> 2509518

Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.

J T Lee1, D J Innes, M E Williams.   

Abstract

We report a case of untreated non-Hodgkin's lymphoma with histologic progression over 1 yr from a low-grade, small cleaved follicular center cell lymphoma to a high-grade, small noncleaved follicular center cell lymphoma. Both lymphomas had identical immunoglobulin (Ig) heavy-chain joining gene (JH), kappa light-chain joining gene, and bcl-2 gene rearrangements, indicating the clonal identity of the two tumors. The Ig heavy chain locus on one chromosome 14 was involved in an initial t(14; 18) translocation as shown by comigrating JH and bcl-2 rearrangements. However, the oncogene c-myc was in the germline configuration in the initial lymphoma but had one allele rearranged near the 3' end of exon I in the high-grade tumor; DNA sequence analysis was consistent with a chromosomal breakpoint at that site. The presence of the c-myc rearrangement in the high-grade tumor suggest a role for c-myc in the clonal evolution of the low-grade tumor into a more aggressive lymphoma. The coexistence of both bcl-2 gene and c-myc oncogene rearrangements in the same tumor is unusual, with only a few cases reported. Furthermore, this case is unique in the direct demonstration of the histologic and clinical progression of a human lymphoma associated with the sequential rearrangement of the bcl-2 gene and the c-myc oncogene.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2509518      PMCID: PMC304009          DOI: 10.1172/JCI114320

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Progression of follicular large cell lymphoma to Burkitt's lymphoma.

Authors:  R L Sham; P Phatak; J Carignan; J Janas; J P Olson
Journal:  Cancer       Date:  1989-02-15       Impact factor: 6.860

2.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

3.  Molecular events in tumor development.

Authors:  P C Nowell
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

4.  The bcl-2 gene is rearranged in many diffuse B-cell lymphomas.

Authors:  A C Aisenberg; B M Wilkes; J O Jacobson
Journal:  Blood       Date:  1988-04       Impact factor: 22.113

5.  New approaches to the classification of the lymphomata.

Authors:  R J Lukes; R D Collins
Journal:  Br J Cancer Suppl       Date:  1975-03

6.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

7.  Pre-B-cell leukemia with a t(8; 14) and a t(14; 18) translocation is preceded by follicular lymphoma.

Authors:  C E Gauwerky; J Hoxie; P C Nowell; C M Croce
Journal:  Oncogene       Date:  1988-05       Impact factor: 9.867

8.  Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation.

Authors:  B Y Ngan; Z Chen-Levy; L M Weiss; R A Warnke; M L Cleary
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

9.  A point mutation in the c-myc locus of a Burkitt lymphoma abolishes binding of a nuclear protein.

Authors:  M Zajac-Kaye; E P Gelmann; D Levens
Journal:  Science       Date:  1988-06-24       Impact factor: 47.728

10.  Correlation of secondary cytogenetic abnormalities with histologic appearance in non-Hodgkin's lymphomas bearing t(14;18)(q32;q21).

Authors:  J O Armitage; W G Sanger; D D Weisenburger; D S Harrington; J Linder; P J Bierman; J M Vose; D T Purtilo
Journal:  J Natl Cancer Inst       Date:  1988-06-15       Impact factor: 13.506

View more
  14 in total

1.  B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Authors:  Matija Snuderl; Olga K Kolman; Yi-Bin Chen; Jessie J Hsu; Adam M Ackerman; Paola Dal Cin; Judith A Ferry; Nancy Lee Harris; Robert P Hasserjian; Lawrence R Zukerberg; Jeremy S Abramson; Ephraim P Hochberg; Hang Lee; Alfred I Lee; Christiana E Toomey; Aliyah R Sohani
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

2.  Simultaneous occurrence of t(14;18) and t(8;22) common acute lymphoblastic leukemia.

Authors:  C Marosi; P Bettelheim; A Chott; U Köller; G Kreiner; G Steger; U Jäger; H Pirc-Danoewinata; K Lechner
Journal:  Ann Hematol       Date:  1992-02       Impact factor: 3.673

Review 3.  Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases.

Authors:  Andreas Strasser; Suzanne Cory; Jerry M Adams
Journal:  EMBO J       Date:  2011-08-23       Impact factor: 11.598

4.  Synergistic effect of Bcl2, Myc and Ccnd1 transforms mouse primary B cells into malignant cells.

Authors:  Masao Nakagawa; Shinobu Tsuzuki; Keiichiro Honma; Osamu Taguchi; Masao Seto
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

5.  BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL).

Authors:  M Butler; N Corbally; P A Dervan; D N Carney
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Rearrangements of c-myc and c-abl genes in tumour cells in Burkitt's lymphoma.

Authors:  S Casares; J M Rodríguez; A Martin; A Parrado
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

7.  Translocation (14; 18) and (8; 22) in three patients with acute leukemia/lymphoma following centrocytic/centroblastic non-Hodgkin's lymphoma.

Authors:  W Fiedler; H J Weh; W Zeller; C Fonatsch; J Hillion; C Larsen; B Wörmann; D K Hossfeld
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

Review 8.  Pitfalls in diagnostic hematopathology -- Part II.

Authors:  Xianfeng F Zhao
Journal:  Int J Clin Exp Pathol       Date:  2009-09-10

Review 9.  Decoding and unlocking the BCL-2 dependency of cancer cells.

Authors:  Philippe Juin; Olivier Geneste; Fabien Gautier; Stéphane Depil; Mario Campone
Journal:  Nat Rev Cancer       Date:  2013-06-20       Impact factor: 60.716

Review 10.  Atypical Burkitt's lymphoma transforming from follicular lymphoma.

Authors:  Yu Y Hwang; Florence Loong; Lap P Chung; Chor S Chim
Journal:  Diagn Pathol       Date:  2011-07-08       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.